Canasa 1000 mg Rectal Suppository
RxNorm 583257
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 583257 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Canasa 1000 mg Rectal Suppository.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
Canasa 1000 mg Rectal Suppository
(Atom ID: 6812206)
SYPrescribable
Synonym (SY):
Canasa 1000 mg Rectal Suppository
(Atom ID: 2310049)
SBDPrescribable
Semantic Branded Drug (SBD):
Mesalamine 1000 mg Rectal Suppository [Canasa]
(Atom ID: 2357585)
Patient Education
Mesalamine Rectal
Rectal mesalamine is used to treat ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum), proctitis (swelling in the rectum), and proctosigmoiditis (swelling in the rectum and sigmoid colon [last section of the colon]). Rectal mesalamine is in a class of medications called anti-inflammatory agents. It works by stopping the body from producing a certain substance that may cause inflammation.
[Learn More]
* Please review the disclaimer below.